CD133 MicroBead Kit, human

Name: CD133 MicroBead Kit, human
Availability: InStock

CD133 MicroBead Kit, human

The CD133 MicroBead Kit allows basic isolation or depletion of CD133

⁺

cells from various sources.

Note:

Optimized isolation kits with improved performance are available for the following tissues:

For hematopoietic or endothelial progenitor cells, choose the CD133 MicroBead Kit – Hematopoietic Tissue
For cancer or tissue stem cells the CD133 MicroBead Kit – Tumor Tissue is recommended

Product data and images for CD133 MicroBead Kit, human

Figures

Figure 1

Isolation of CD133

⁺

cells from human PBMCs using the CD133 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator.

PBMCs before separation	Isolated CD133 ⁺ cells
View details CD133 MicroBead Kit, human Figure 1 Isolation of CD133 ⁺ cells from human PBMCs using the CD133 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator.	View details CD133 MicroBead Kit, human Figure 1 Isolation of CD133 ⁺ cells from human PBMCs using the CD133 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator.

Specifications for CD133 MicroBead Kit, human

Overview

The CD133 MicroBead Kit allows basic isolation or depletion of CD133

⁺

cells from various sources.

Note:

Optimized isolation kits with improved performance are available for the following tissues:

For hematopoietic or endothelial progenitor cells, choose the CD133 MicroBead Kit – Hematopoietic Tissue
For cancer or tissue stem cells the CD133 MicroBead Kit – Tumor Tissue is recommended

Detailed product information

Background information

CD133, formerly known as AC133, recognizes epitope 1 of the CD133 antigen.

^2,3

It is a marker that is frequently found on multipotent progenitor cells, including immature hematopoietic stem and progenitor cells. In the hematopoietic system, CD133 is expressed on a small portion of CD34

^–

cells

⁴

as well as on a subset of CD34

^bright

stem and progenitor cells in human fetal liver, bone marrow, cord blood, and peripheral blood

⁵

. CD133 has also been found to be expressed on circulating endothelial progenitor cells,

^6,7

fetal neural stem cells,

^8,9

other tissue-specific stem cells, such as renal

¹⁰

, prostate

¹¹

, and corneal

¹²

stem cells, cancer stem cells from tumor tissues, as well as ES and iPS cell-derived cells.

There is a growing interest in CD133-expressing stem cells from normal blood or bone marrow in regenerative medicine, for example, in the field of cardiovascular

^13-17

, liver, or peripheral artery diseases

^18-20

.

The CD133 MicroBeads included in the kit recognize epitope CD133/1. For quality control staining of isolated CD133

⁺

cells, the use of CD133/2 (293C3)-PE or -APC is recommended.

Columns

For positive selection: MS, LS, XS, or autoMACS

^®

Columns. For depletion: LD, D, or autoMACS Columns.

Resources for CD133 MicroBead Kit, human

Documents and Protocols

Brochures/posters

Neuroscience - Inspiring technologies for creative scientists

Brochures/posters

Cancer Research - Understanding cancer begins with the cell

App notes/customer reports

Intracellular labeling of multiple cell types for MRI-based in vivo cell tracking.

App notes/customer reports

Array-based analysis of microRNA and mRNA expression characterizes early differentiation pathways of CD133⁺ and CD34⁺ hematopoietic stem and progenitor cells.

References for CD133 MicroBead Kit, human

Publications

Galic, Z. et al. (2006) T lineage differentiation from human embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 103: 11742-11747
Yin, A. H. et al. (1997) AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90: 5002-5012
Piechaczek, C. (2001) CD133. J. Biol. Regul. Homeost. Agents 15: 101-102
Gallacher, L. et al. (2000)
Isolation and characterization of human CD34
^–
Lin
^–
and CD34
⁺
Lin
^–
hematopoietic stem cells using cell surface markers AC133 and CD7.
Blood 95(ARVO Annual Meeting Abstract): 2813-2820
Bühring, H. J. et al. (1999) Expression of novel surface antigens on early hematopoietic cells. Ann. N. Y. Acad. Sci. 872: 25-39
Gehling, U. M. et al. (2000)
In vitro
differentiation of endothelial cells from AC133-positive progenitor cells.
Blood 95: 3106-3112
Peichev, M. et al. (2000)
Expression of VEGFR-2 and AC133 by circulating human CD34
⁺
cells identifies a population of functional endothelial precursors.
Blood 95: 952-958
Uchida, N. et al. (2000) Direct isolation of human central nervous system stem cells. Proc. Natl. Acad. Sci. U.S.A. 97: 14720-14725
Cummings, B. J. et al. (2005) Human neural stem cells differentiate and promote locometer recovery in spinal cord-injured mice. Proc. Natl. Acad. Sci. U.S.A. 102: 14069-14074
Bussolati, B. et al. (2005) Isolation of renal progenitor cells from adult human kidney. Am. J. Pathol. 166: 545-555
Richardson, G. et al. (2004) CD133, a novel marker for human prostatic epithelial stem cells. J. Cell. Sci. 117: 3539-3545
Thill, M. et al. (2004)
Identification of a population of CD133
⁺
precursor cells in the stroma of human cornea.
Invest. Ophthalmol. Vis. Sci. 45: 3519
Stamm, C. et al. (2003) Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361(9351): 45-46
Stamm, C. et al. (2007)
Intramyocardial delivery of CD133
⁺
bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies.
J. Thorac. Cardiovasc. Surg. 133: 717-725
Klein (2007) Eur. Cardiovasc. Dis. 1: 123-125
Klein, H. M. et al. (2007)
Intramyocardial implantation of CD133
⁺
stem cells improved cardiac function without bypass surgery.
Heart Surg. Forum 10: E66-69
Bartunek et al. (2005) Circulation 30: 178-183
Schulte am Esch 2nd, J. et al. (2005)
Portal application of autologous CD133
⁺
bone marrow cells to the liver: a novel concept to support hepatic regeneration.
Stem Cells 23(4): 463-470
Fürst, G. et al. (2007)
Portal vein embolization and autologous CD133
⁺
bone marrow stem cells for liver regeneration: initial experience.
J. Immunother. 243(1): 171-179
Cañizo, M. C. et al. (2007)
Peripheral endothelial progenitor cells (CD133
⁺
) for therapeutic vasculogenesis in a patient with critical limb ischemia. One year follow-up.
Cytotherapy 9(1): 99-102

Data and images

Data and images for CD133 MicroBead Kit, human

Figures

Figure 1

Isolation of CD133

⁺

cells from human PBMCs using the CD133 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator.

PBMCs before separation	Isolated CD133 ⁺ cells
View details CD133 MicroBead Kit, human Figure 1 Isolation of CD133 ⁺ cells from human PBMCs using the CD133 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator.	View details CD133 MicroBead Kit, human Figure 1 Isolation of CD133 ⁺ cells from human PBMCs using the CD133 MicroBead Kit, two MS Columns, and a MiniMACS™ Separator.

Specifications

Specifications for CD133 MicroBead Kit, human

Overview

The CD133 MicroBead Kit allows basic isolation or depletion of CD133

⁺

cells from various sources.

Note:

Optimized isolation kits with improved performance are available for the following tissues:

For hematopoietic or endothelial progenitor cells, choose the CD133 MicroBead Kit – Hematopoietic Tissue
For cancer or tissue stem cells the CD133 MicroBead Kit – Tumor Tissue is recommended

Detailed product information

Background information

CD133, formerly known as AC133, recognizes epitope 1 of the CD133 antigen.

^2,3

It is a marker that is frequently found on multipotent progenitor cells, including immature hematopoietic stem and progenitor cells. In the hematopoietic system, CD133 is expressed on a small portion of CD34

^–

cells

⁴

as well as on a subset of CD34

^bright

stem and progenitor cells in human fetal liver, bone marrow, cord blood, and peripheral blood

⁵

. CD133 has also been found to be expressed on circulating endothelial progenitor cells,

^6,7

fetal neural stem cells,

^8,9

other tissue-specific stem cells, such as renal

¹⁰

, prostate

¹¹

, and corneal

¹²

stem cells, cancer stem cells from tumor tissues, as well as ES and iPS cell-derived cells.

There is a growing interest in CD133-expressing stem cells from normal blood or bone marrow in regenerative medicine, for example, in the field of cardiovascular

^13-17

, liver, or peripheral artery diseases

^18-20

.

The CD133 MicroBeads included in the kit recognize epitope CD133/1. For quality control staining of isolated CD133

⁺

cells, the use of CD133/2 (293C3)-PE or -APC is recommended.

Columns

For positive selection: MS, LS, XS, or autoMACS

^®

Columns. For depletion: LD, D, or autoMACS Columns.

Resources

Resources for CD133 MicroBead Kit, human

Documents and Protocols

Brochures/posters

Array-based analysis of microRNA and mRNA expression characterizes early differentiation pathways of CD133⁺ and CD34⁺ hematopoietic stem and progenitor cells.

References

References for CD133 MicroBead Kit, human

Publications

Galic, Z. et al. (2006) T lineage differentiation from human embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 103: 11742-11747
Yin, A. H. et al. (1997) AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90: 5002-5012
Piechaczek, C. (2001) CD133. J. Biol. Regul. Homeost. Agents 15: 101-102
Gallacher, L. et al. (2000)
Isolation and characterization of human CD34
^–
Lin
^–
and CD34
⁺
Lin
^–
hematopoietic stem cells using cell surface markers AC133 and CD7.
Blood 95(ARVO Annual Meeting Abstract): 2813-2820
Bühring, H. J. et al. (1999) Expression of novel surface antigens on early hematopoietic cells. Ann. N. Y. Acad. Sci. 872: 25-39
Gehling, U. M. et al. (2000)
In vitro
differentiation of endothelial cells from AC133-positive progenitor cells.
Blood 95: 3106-3112
Peichev, M. et al. (2000)
Expression of VEGFR-2 and AC133 by circulating human CD34
⁺
cells identifies a population of functional endothelial precursors.
Blood 95: 952-958
Uchida, N. et al. (2000) Direct isolation of human central nervous system stem cells. Proc. Natl. Acad. Sci. U.S.A. 97: 14720-14725
Cummings, B. J. et al. (2005) Human neural stem cells differentiate and promote locometer recovery in spinal cord-injured mice. Proc. Natl. Acad. Sci. U.S.A. 102: 14069-14074
Bussolati, B. et al. (2005) Isolation of renal progenitor cells from adult human kidney. Am. J. Pathol. 166: 545-555
Richardson, G. et al. (2004) CD133, a novel marker for human prostatic epithelial stem cells. J. Cell. Sci. 117: 3539-3545
Thill, M. et al. (2004)
Identification of a population of CD133
⁺
precursor cells in the stroma of human cornea.
Invest. Ophthalmol. Vis. Sci. 45: 3519
Stamm, C. et al. (2003) Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361(9351): 45-46
Stamm, C. et al. (2007)
Intramyocardial delivery of CD133
⁺
bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies.
J. Thorac. Cardiovasc. Surg. 133: 717-725
Klein (2007) Eur. Cardiovasc. Dis. 1: 123-125
Klein, H. M. et al. (2007)
Intramyocardial implantation of CD133
⁺
stem cells improved cardiac function without bypass surgery.
Heart Surg. Forum 10: E66-69
Bartunek et al. (2005) Circulation 30: 178-183
Schulte am Esch 2nd, J. et al. (2005)
Portal application of autologous CD133
⁺
bone marrow cells to the liver: a novel concept to support hepatic regeneration.
Stem Cells 23(4): 463-470
Fürst, G. et al. (2007)
Portal vein embolization and autologous CD133
⁺
bone marrow stem cells for liver regeneration: initial experience.
J. Immunother. 243(1): 171-179
Cañizo, M. C. et al. (2007)
Peripheral endothelial progenitor cells (CD133
⁺
) for therapeutic vasculogenesis in a patient with critical limb ischemia. One year follow-up.
Cytotherapy 9(1): 99-102

Related products for
CD133 MicroBead Kit, human

12 products available | view all view less

Seems like you are coming from USA!
Do you want to visit our website in your country?

CD133 MicroBead Kit, human

CD133 MicroBead Kit, human

Product data and images for CD133 MicroBead Kit, human

Figures

Figure 1